Lifestyle interventions in cardiometabolic HFpEF: dietary and exercise modalities.

Borlaug BA, Sharma K, Shah SJ, Ho JE (2023) Heart failure with preserved ejection fraction: JACC scientific statement. J Am Coll Cardiol 81:1810–1834. https://doi.org/10.1016/j.jacc.2023.01.049

doi: 10.1016/j.jacc.2023.01.049 pubmed: 37137592

Roh J, Hill JA, Singh A, Valero-Muñoz M, Sam F (2022) Heart failure with preserved ejection fraction: heterogeneous syndrome, diverse preclinical models. Circ Res 130:1906–1925. https://doi.org/10.1161/CIRCRESAHA.122.320257

doi: 10.1161/CIRCRESAHA.122.320257 pubmed: 35679364 pmcid: 10035274

Dunlay SM, Roger VL, Redfield MM (2017) Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol 14:591–602. https://doi.org/10.1038/nrcardio.2017.65

doi: 10.1038/nrcardio.2017.65 pubmed: 28492288

Shah SJ, Borlaug BA, Kitzman DW, McCulloch AD, Blaxall BC, Agarwal R, Chirinos JA, Collins S, Deo RC, Gladwin MT, Granzier H, Hummel SL, Kass DA, Redfield MM, Sam F, Wang TJ, Desvigne-Nickens P, Adhikari BB (2020) Research priorities for heart failure with preserved ejection fraction: national heart, lung, and blood institute working group summary. Circulation 141:1001–1026. https://doi.org/10.1161/CIRCULATIONAHA.119.041886

doi: 10.1161/CIRCULATIONAHA.119.041886 pubmed: 32202936 pmcid: 7101072

Borlaug BA, Redfield MM (2011) Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum. Circulation 123:2006–2014. https://doi.org/10.1161/CIRCULATIONAHA.110.954388

doi: 10.1161/CIRCULATIONAHA.110.954388 pubmed: 21555723 pmcid: 3420141

Figtree GA, Rådholm K, Barrett TD, Perkovic V, Mahaffey KW, De Zeeuw D, Fulcher G, Matthews DR, Shaw W, Neal B (2019) Effects of canagliflozin on heart failure outcomes associated with preserved and reduced ejection fraction in type 2 diabetes mellitus: results from the CANVAS program. Circulation 139:2591–2593. https://doi.org/10.1161/CIRCULATIONAHA.119.040057

doi: 10.1161/CIRCULATIONAHA.119.040057 pubmed: 30882240

Dyck JRB, Sossalla S, Hamdani N, Coronel R, Weber NC, Light PE, Zuurbier CJ (2022) Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: evidence for potential off-target effects. J Mol Cell Cardiol 167:17–31. https://doi.org/10.1016/j.yjmcc.2022.03.005

doi: 10.1016/j.yjmcc.2022.03.005 pubmed: 35331696

Capone F, Nambiar N, Schiattarella GG (2024) Beyond weight loss: the emerging role of incretin-based treatments in cardiometabolic HFpEF. Curr Opin Cardiol. https://doi.org/10.1097/HCO.0000000000001117

doi: 10.1097/HCO.0000000000001117 pubmed: 38294187

Borlaug BA (2020) Evaluation and management of heart failure with preserved ejection fraction. Nat Rev Cardiol 17:559–573. https://doi.org/10.1038/s41569-020-0363-2

doi: 10.1038/s41569-020-0363-2 pubmed: 32231333

Schiattarella GG, Hill JA (2021) Cardiometabolic HFpEF: mechanisms and therapies. Cardiometab Syndr J 1:117. https://doi.org/10.51789/cmsj.2021.1.e18

doi: 10.51789/cmsj.2021.1.e18

Lobstein T, Jackson-Leach R, Powis J, Brinsden H, Gray M (2023) World Obesity Atlas 2023. https://www.worldobesity.org/resources/resource-library/world-obesity-atlas-2023

Guo L, Liu X, Yu P, Zhu W (2022) The “obesity paradox” in patients with HFpEF with or without comorbid atrial fibrillation. Front Cardiovasc Med 8:743327. https://doi.org/10.3389/fcvm.2021.743327

doi: 10.3389/fcvm.2021.743327 pubmed: 35087875 pmcid: 8787078

Haass M, Kitzman DW, Anand IS, Miller A, Zile MR, Massie BM, Carson PE (2011) Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the irbesartan in heart failure with preserved ejection fraction (I-PRESERVE) trial. Circ: Heart Failure 4:324–331. https://doi.org/10.1161/CIRCHEARTFAILURE.110.959890

Schiattarella GG, Alcaide P, Condorelli G, Gillette TG, Heymans S, Jones EAV, Kallikourdis M, Lichtman A, Marelli-Berg F, Shah SJ, Thorp EB, Hill JA (2022) Immunometabolic mechanisms of heart failure with preserved ejection fraction. Nat Cardiovasc Res 1:211–222. https://doi.org/10.1038/s44161-022-00032-w

doi: 10.1038/s44161-022-00032-w pubmed: 35755006 pmcid: 9229992

Shah MS, Brownlee M (2016) Molecular and cellular mechanisms of cardiovascular disorders in diabetes. Circ Res 118:1808–1829. https://doi.org/10.1161/CIRCRESAHA.116.306923

doi: 10.1161/CIRCRESAHA.116.306923 pubmed: 27230643 pmcid: 4888901

Carbone S, Mauro AG, Mezzaroma E, Kraskauskas D, Marchetti C, Buzzetti R, Van Tassell BW, Abbate A, Toldo S (2015) A high-sugar and high-fat diet impairs cardiac systolic and diastolic function in mice. Int J Cardiol 198:66–69. https://doi.org/10.1016/j.ijcard.2015.06.136

doi: 10.1016/j.ijcard.2015.06.136 pubmed: 26151718

La Gerche A, Howden EJ, Haykowsky MJ, Lewis GD, Levine BD, Kovacic JC (2022) Heart failure with preserved ejection fraction as an exercise deficiency syndrome. J Am Coll Cardiol 80:1177–1191. https://doi.org/10.1016/j.jacc.2022.07.011

doi: 10.1016/j.jacc.2022.07.011 pubmed: 36075837

Capone F, Sotomayor-Flores C, Bode D, Wang R, Rodolico D, Strocchi S, Schiattarella GG (2023) Cardiac metabolism in HFpEF: from fuel to signalling. Cardiovasc Res 118:3556–3575. https://doi.org/10.1093/cvr/cvac166

doi: 10.1093/cvr/cvac166 pubmed: 36504368

American Heart Association Life’s Simple 7® Journey to Health

Aggarwal M, Bozkurt B, Panjrath G, Aggarwal B, Ostfeld RJ, Barnard ND, Gaggin H, Freeman AM, Allen K, Madan S, Massera D, Litwin SE (2018) Lifestyle modifications for preventing and treating heart failure. J Am Coll Cardiol 72:2391–2405. https://doi.org/10.1016/j.jacc.2018.08.2160

doi: 10.1016/j.jacc.2018.08.2160 pubmed: 30384895

Bohmke NJ, Billingsley HE, Kirkman DL, Carbone S (2022) Nonpharmacological strategies in heart failure with preserved ejection fraction. Cardiol Clin 40:491–506. https://doi.org/10.1016/j.ccl.2022.06.003

doi: 10.1016/j.ccl.2022.06.003 pubmed: 36210133 pmcid: 10280381

Larsson SC, Tektonidis TG, Gigante B, Åkesson A, Wolk A (2016) Healthy lifestyle and risk of heart failure: results from 2 prospective cohort studies. Circ: Heart Failure 9:e002855. https://doi.org/10.1161/CIRCHEARTFAILURE.115.002855

Lara KM, Levitan EB, Gutierrez OM, Shikany JM, Safford MM, Judd SE, Rosenson RS (2019) Dietary patterns and incident heart failure in U.S. adults without known coronary disease. J Am Coll Cardiol 73:2036–2045. https://doi.org/10.1016/j.jacc.2019.01.067

doi: 10.1016/j.jacc.2019.01.067 pubmed: 31023426 pmcid: 6501554

Folsom AR, Shah AM, Lutsey PL, Roetker NS, Alonso A, Avery CL, Miedema MD, Konety S, Chang PP, Solomon SD (2015) American Heart Association’s Life’s Simple 7: avoiding heart failure and preserving cardiac structure and function. Am J Med 128:970-976.e2. https://doi.org/10.1016/j.amjmed.2015.03.027

doi: 10.1016/j.amjmed.2015.03.027 pubmed: 25908393 pmcid: 4554769

Carbone S, Canada JM, Buckley LF, Trankle CR, Dixon DL, Buzzetti R, Arena R, Van Tassell BW, Abbate A (2016) Obesity contributes to exercise intolerance in heart failure with preserved ejection fraction. J Am Coll Cardiol 68:2487–2488. https://doi.org/10.1016/j.jacc.2016.08.072

doi: 10.1016/j.jacc.2016.08.072 pubmed: 27908355 pmcid: 5748881

Levitan EB, Lewis CE, Tinker LF, Eaton CB, Ahmed A, Manson JE, Snetselaar LG, Martin LW, Trevisan M, Howard BV, Shikany JM (2013) Mediterranean and DASH diet scores and mortality in women with heart failure: the women’s health initiative. Circ: Heart Failure 6:1116–1123. https://doi.org/10.1161/CIRCHEARTFAILURE.113.000495

Carbone S, Canada JM, Buckley LF, Trankle CR, Billingsley HE, Dixon DL, Mauro AG, Dessie S, Kadariya D, Mezzaroma E, Buzzetti R, Arena R, Van Tassell BW, Toldo S, Abbate A (2017) Dietary fat, sugar consumption, and cardiorespiratory fitness in patients with heart failure with preserved ejection fraction. JACC: Basic to Translational Science 2:513–525. https://doi.org/10.1016/j.jacbts.2017.06.009

Kim MY, Pellot I, Bresee C, Nawaz A, Fournier M, Cho JH, Cingolani E (2023) Diet modification reverses diastolic dysfunction in rats with heart failure and preserved ejection fraction. J Molec Cell Cardiol Plus 3:100031. https://doi.org/10.1016/j.jmccpl.2023.100031

doi: 10.1016/j.jmccpl.2023.100031

Shah SJ (2017) Sedentary lifestyle and the risk for HFpEF. J Am Coll Cardiol 69:1143–1146. https://doi.org/10.1016/j.jacc.2017.01.010

doi: 10.1016/j.jacc.2017.01.010 pubmed: 28254176

McGee SL, Hargreaves M (2020) Exercise adaptations: molecular mechanisms and potential targets for therapeutic benefit. Nat Rev Endocrinol 16:495–505. https://doi.org/10.1038/s41574-020-0377-1

doi: 10.1038/s41574-020-0377-1 pubmed: 32632275

Fiuza-Luces C, Santos-Lozano A, Joyner M, Carrera-Bastos P, Picazo O, Zugaza JL, Izquierdo M, Ruilope LM, Lucia A (2018) Exercise benefits in cardiovascular disease: beyond attenuation of traditional risk factors. Nat Rev Cardiol 15:731–743. https://doi.org/10.1038/s41569-018-0065-1

doi: 10.1038/s41569-018-0065-1 pubmed: 30115967

Nayor M, Shah RV, Miller PE, Blodgett JB, Tanguay M, Pico AR, Murthy VL, Malhotra R, Houstis NE, Deik A, Pierce KA, Bullock K, Dailey L, Velagaleti RS, Moore SA, Ho JE, Baggish AL, Clish CB, Larson MG, Vasan RS, Lewis GD (2020) Metabolic architecture of acute exercise response in middle-aged adults in the community. Circulation 142:1905–1924. https://doi.org/10.1161/CIRCULATIONAHA.120.050281

doi: 10.1161/CIRCULATIONAHA.120.050281 pubmed: 32927962 pmcid: 8049528

Tune JD, Goodwill AG, Sassoon DJ, Mather KJ (2017) Cardiovascular consequences of metabolic syndrome. Transl Res 183:57–70. https://doi.org/10.1016/j.trsl.2017.01.001

doi: 10.1016/j.trsl.2017.01.001 pubmed: 28130064 pmcid: 5393930

Gutiérrez-Cuevas J, Sandoval-Rodriguez A, Meza-Rios A, Monroy-Ramírez HC, Galicia-Moreno M, García-Bañuelos J, Santos A, Armendariz-Borunda J (2021) Molecular mechanisms of obesity-linked cardiac dysfunction: an up-date on current knowledge. Cells 10:629. https://doi.org/10.3390/cells10030629

doi: 10.3390/cells10030629 pubmed: 33809061 pmcid: 8000147

Henry JA, Couch LS, Rider OJ (2024) Myocardial metabolism in heart failure with preserved ejection fraction. JCM 13:1195. https://doi.org/10.3390/jcm13051195

doi: 10.3390/jcm13051195 pubmed: 38592048 pmcid: 10931709

Hahn VS, Petucci C, Kim M-S, Bedi KC, Wang H, Mishra S, Koleini N, Yoo EJ, Margulies KB, Arany Z, Kelly DP, Kass DA, Sharma K (2023) Myocardial metabolomics of human heart failure with preserved ejection fraction. Circulation 147:1147–1161. https://doi.org/10.1161/CIRCULATIONAHA.122.061846

doi: 10.1161/CIRCULATIONAHA.122.061846 pubmed: 36856044 pmcid: 11059242

Murashige D, Jang C, Neinast M, Edwards JJ, Cowan A, Hyman MC, Rabinowitz JD, Frankel DS, Arany Z (2020) Comprehensive quantification of fuel use by the failing and nonfailing human heart. Science 370:364–368. https://doi.org/10.1126/science.abc8861

doi: 10.1126/science.abc8861 pubmed: 33060364 pmcid: 7871704

Tong D, Schiattarella GG, Jiang N, Altamirano F, Szweda PA, Elnwasany A, Lee DI, Yoo H, Kass DA, Szweda LI, Lavandero S, Verdin E, Gillette TG, Hill JA (2021) NAD

doi: 10.1161/CIRCRESAHA.120.317046 pubmed: 33882692 pmcid: 8159891

Sun Q, Güven B, Wagg CS, Almeida De Oliveira A, Silver H, Zhang L, Chen B, Wei K, Ketema EB, Karwi QG, Persad KL, Vu J, Wang F, Dyck JRB, Oudit GY, Lopaschuk GD (2024) Mitochondrial fatty acid oxidation is the major source of cardiac adenosine triphosphate production in heart failure with preserved ejection fraction. Cardiovasc Res 120:360–371. https://doi.org/10.1093/cvr/cvae006

doi: 10.1093/cvr/cvae006 pubmed: 38193548

Rijzewijk LJ, Van Der Meer RW, Lamb HJ, De Jong HWAM, Lubberink M, Romijn JA, Bax JJ, De Roos A, Twisk JW, Heine RJ, Lammertsma AA, Smit JWA, Diamant M (2009) Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy. J Am Coll Cardiol 54:1524–1532. https://doi.org/10.1016/j.jacc.2009.04.074

doi: 10.1016/j.jacc.2009.04.074 pubmed: 19815124

Barouch LA, Berkowitz DE, Harrison RW, O’Donnell CP, Hare JM (2003) Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation 108:754–759. https://doi.org/10.1161/01.CIR.0000083716.82622.FD

doi: 10.1161/01.CIR.0000083716.82622.FD pubmed: 12885755

Zhang L, Jaswal JS, Ussher JR, Sankaralingam S, Wagg C, Zaugg M, Lopaschuk GD (2013) Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy. Circ Heart Failure 6:1039–1048. https://doi.org/10.1161/CIRCHEARTFAILURE.112.000228

doi: 10.1161/CIRCHEARTFAILURE.112.000228 pubmed: 23861485

Mori J, Basu R, McLean BA, Das SK, Zhang L, Patel VB, Wagg CS, Kassiri Z, Lopaschuk GD, Oudit GY (2012) Agonist-induced hypertrophy and diastolic dysfunction are associated with selective reduction in glucose oxidation: a metabolic contribution to heart failure with normal ejection fraction. Circ Heart Failure 5:493–503. https://doi.org/10.1161/CIRCHEARTFAILURE.112.966705

doi: 10.1161/CIRCHEARTFAILURE.112.966705 pubmed: 22705769

Mori J, Alrob OA, Wagg CS, Harris RA, Lopaschuk GD, Oudit GY (2013) ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4. Am J Physiol-Heart Circ Physiol 304:H1103–H1113. https://doi.org/10.1152/ajpheart.00636.2012

doi: 10.1152/ajpheart.00636.2012 pubmed: 23396452

Morigny P, Houssier M, Mouisel E, Langin D (2016) Adipocyte lipolysis and insulin resistance. Biochimie 125:259–266. https://doi.org/10.1016/j.biochi.2015.10.024

doi: 10.1016/j.biochi.2015.10.024 pubmed: 26542285

Leggat J, Bidault G, Vidal-Puig A (2021) Lipotoxicity: a driver of heart failure with preserved ejection fraction? Clin Sci 135:2265–2283. https://doi.org/10.1042/CS20210127

doi: 10.1042/CS20210127

Neubauer S (2007) The failing heart—an engine out of fuel. N Engl J Med 356:1140–1151. https://doi.org/10.1056/NEJMra063052

doi: 10.1056/NEJMra063052 pubmed: 17360992

Burrage MK, Lewis AJ, Miller JJJ (2023) Functional and metabolic imaging in heart failure with preserved ejection fraction: promises, challenges, and clinical utility. Cardiovasc Drugs Ther 37:379–399. https://doi.org/10.1007/s10557-022-07355-7

doi: 10.1007/s10557-022-07355-7 pubmed: 35881280

Karwi QG, Uddin GM, Ho KL, Lopaschuk GD (2018) Loss of metabolic flexibility in the failing heart. Front Cardiovasc Med 5:68. https://doi.org/10.3389/fcvm.2018.00068

doi: 10.3389/fcvm.2018.00068 pubmed: 29928647 pmcid: 5997788

Burrage MK, Hundertmark M, Valkovič L, Watson WD, Rayner J, Sabharwal N, Ferreira VM, Neubauer S, Miller JJ, Rider OJ, Lewis AJM (2021) Energetic basis for exercise-induced pulmonary congestion in heart failure with preserved ejection fraction. Circulation 144:1664–1678. https://doi.org/10.1161/CIRCULATIONAHA.121.054858

doi: 10.1161/CIRCULATIONAHA.121.054858 pubmed: 34743560 pmcid: 8601674

Mahmod M, Pal N, Rayner J, Holloway C, Raman B, Dass S, Levelt E, Ariga R, Ferreira V, Banerjee R, Schneider JE, Rodgers C, Francis JM, Karamitsos TD, Frenneaux M, Ashrafian H, Neubauer S, Rider O (2018) The interplay between metabolic alterations, diastolic strain rate and exercise capacity in mild heart failure with preserved ejection fraction: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 20:88. https://doi.org/10.1186/s12968-018-0511-6

doi: 10.1186/s12968-018-0511-6 pubmed: 30580760 pmcid: 6304764

Phan TT, Abozguia K, Nallur Shivu G, Mahadevan G, Ahmed I, Williams L, Dwivedi G, Patel K, Steendijk P, Ashrafian H, Henning A, Frenneaux M (2009) Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency. J Am Coll Cardiol 54:402–409. https://doi.org/10.1016/j.jacc.2009.05.012

doi: 10.1016/j.jacc.2009.05.012 pubmed: 19628114

Beer M, Seyfarth T, Sandstede J, Landschütz W, Lipke C, Köstler H, Von Kienlin M, Harre K, Hahn D, Neubauer S (2002) Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with 31P-SLOOP magnetic resonance spectroscopy. J Am Coll Cardiol 40:1267–1274. https://doi.org/10.1016/S0735-1097(02)02160-5

doi: 10.1016/S0735-1097(02)02160-5 pubmed: 12383574

De Wit-Verheggen VHW, Schrauwen-Hinderling VB, Brouwers K, Jörgensen JA, Schaart G, Gemmink A, Nascimento EBM, Hesselink MKC, Wildberger JE, Segers P, Montaigne D, Staels B, Schrauwen P, Lindeboom L, Hoeks J, Van De Weijer T (2023) PCr/ATP ratios and mitochondrial function in the heart. a comparative study in humans. Sci Rep 13:8346. https://doi.org/10.1038/s41598-023-35041-7

doi: 10.1038/s41598-023-35041-7 pubmed: 37221197 pmcid: 10205750

Actis Dato V, Lange S, Cho Y (2024) Metabolic flexibility of the heart: the role of fatty acid metabolism in health, heart failure, and cardiometabolic diseases. IJMS 25:1211. https://doi.org/10.3390/ijms25021211

doi: 10.3390/ijms25021211 pubmed: 38279217 pmcid: 10816475

Wang R, Schiattarella GG (2024) Tackling metabolic defects in HFpEF. Eur Heart J 45:1494–1496. https://doi.org/10.1093/eurheartj/ehad884

doi: 10.1093/eurheartj/ehad884 pubmed: 38367012

Schiattarella GG, Rodolico D, Hill JA (2021) Metabolic inflammation in heart failure with preserved ejection fraction. Cardiovasc Res 117:423–434. https://doi.org/10.1093/cvr/cvaa217

doi: 10.1093/cvr/cvaa217 pubmed: 32666082

Franssen C, Chen S, Unger A, Korkmaz HI, De Keulenaer GW, Tschöpe C, Leite-Moreira AF, Musters R, Niessen HWM, Linke WA, Paulus WJ, Hamdani N (2016) Myocardial microvascular inflammatory endothelial activation in heart failure with preserved ejection fraction. JACC Heart Failure 4:312–324. https://doi.org/10.1016/j.jchf.2015.10.007

doi: 10.1016/j.jchf.2015.10.007 pubmed: 26682792

Schiattarella GG, Altamirano F, Tong D, French KM, Villalobos E, Kim SY, Luo X, Jiang N, May HI, Wang ZV, Hill TM, Mammen PPA, Huang J, Lee DI, Hahn VS, Sharma K, Kass DA, Lavandero S, Gillette TG, Hill JA (2019) Nitrosative stress drives heart failure with preserved ejection fraction. Nature 568:351–356. https://doi.org/10.1038/s41586-019-1100-z

doi: 10.1038/s41586-019-1100-z pubmed: 30971818 pmcid: 6635957

Matuschik L, Riabov V, Schmuttermaier C, Sevastyanova T, Weiss C, Klüter H, Kzhyshkowska J (2022) Hyperglycemia induces inflammatory response of human macrophages to cd163-mediated scavenging of hemoglobin-haptoglobin complexes. IJMS 23:1385. https://doi.org/10.3390/ijms23031385

doi: 10.3390/ijms23031385 pubmed: 35163309 pmcid: 8836198

Ouchi N, Parker JL, Lugus JJ, Walsh K (2011) Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11:85–97. https://doi.org/10.1038/nri2921

doi: 10.1038/nri2921 pubmed: 21252989 pmcid: 3518031

Catena C, Colussi G, Martinis F, Pezzutto F, Sechi LA (2013) Plasma glucose levels and left ventricular diastolic function in nondiabetic hypertensive patients. Am J Hypertens 26:1353–1361. https://doi.org/10.1093/ajh/hpt114

doi: 10.1093/ajh/hpt114 pubmed: 23846724

Hulsmans M, Sager HB, Roh JD, Valero-Muñoz M, Houstis NE, Iwamoto Y, Sun Y, Wilson RM, Wojtkiewicz G, Tricot B, Osborne MT, Hung J, Vinegoni C, Naxerova K, Sosnovik DE, Zile MR, Bradshaw AD, Liao R, Tawakol A, Weissleder R, Rosenzweig A, Swirski FK, Sam F, Nahrendorf M (2018) Cardiac macrophages promote diastolic dysfunction. J Exp Med 215:423–440. https://doi.org/10.1084/jem.20171274

doi: 10.1084/jem.20171274 pubmed: 29339450 pmcid: 5789416

Mouton AJ, Li X, Hall ME, Hall JE (2020) Obesity, Hypertension, and cardiac dysfunction: novel roles of immunometabolism in macrophage activation and inflammation. Circ Res 126:789–806. https://doi.org/10.1161/CIRCRESAHA.119.312321

doi: 10.1161/CIRCRESAHA.119.312321 pubmed: 32163341 pmcid: 7255054

Morris E, Jebb SA, Oke J, Nickless A, Ahern A, Boyland E, Caterson ID, Halford J, Hauner H, Aveyard P (2021) Effect of weight loss on cardiometabolic risk: observational analysis of two randomised controlled trials of community weight-loss programmes. Br J Gen Pract 71:e312–e319. https://doi.org/10.3399/bjgp20X714113

doi: 10.3399/bjgp20X714113 pubmed: 33685923 pmcid: 7959667

Lin CH, Kurup S, Herrero P, Schechtman KB, Eagon JC, Klein S, Dávila-Román VG, Stein RI, Dorn-II GW, Gropler RJ, Waggoner AD, Peterson LR (2011) Myocardial oxygen consumption change predicts left ventricular relaxation improvement in obese humans after weight loss. Obesity 19:1804–1812. https://doi.org/10.1038/oby.2011.186

doi: 10.1038/oby.2011.186 pubmed: 21738241

Madigan MJ, Racette SB, Coggan AR, Stein RI, McCue LM, Gropler RJ, Peterson LR (2019) Weight loss affects intramyocardial glucose metabolism in obese humans. Circ Cardiovascular Imaging 12:e009241. https://doi.org/10.1161/CIRCIMAGING.119.009241

doi: 10.1161/CIRCIMAGING.119.009241 pubmed: 31352791

Rider OJ, Francis JM, Tyler D, Byrne J, Clarke K, Neubauer S (2013) Effects of weight loss on myocardial energetics and diastolic function in obesity. Int J Cardiovasc Imaging 29:1043–1050. https://doi.org/10.1007/s10554-012-0174-6

doi: 10.1007/s10554-012-0174-6 pubmed: 23269470

Sarzani R, Landolfo M, Di Pentima C, Ortensi B, Falcioni P, Sabbatini L, Massacesi A, Rampino I, Spannella F, Giulietti F (2024) Adipocentric origin of the common cardiometabolic complications of obesity in the young up to the very old: pathophysiology and new therapeutic opportunities. Front Med 11:1365183. https://doi.org/10.3389/fmed.2024.1365183

doi: 10.3389/fmed.2024.1365183

Forsythe LK, Wallace JMW, Livingstone MBE (2008) Obesity and inflammation: the effects of weight loss. Nutr Res Rev 21:117–133. https://doi.org/10.1017/S0954422408138732

doi: 10.1017/S0954422408138732 pubmed: 19087366

Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM (2003) Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 42:878–884. https://doi.org/10.1161/01.HYP.0000094221.86888.AE

doi: 10.1161/01.HYP.0000094221.86888.AE pubmed: 12975389

Colín Ramírez E, Castillo Martínez L, Orea Tejeda A, Rebollar González V, Narváez David R, Asensio Lafuente E (2004) Effects of a nutritional intervention on body composition, clinical status, and quality of life in patients with heart failure. Nutrition 20:890–895. https://doi.org/10.1016/j.nut.2004.06.010

doi: 10.1016/j.nut.2004.06.010 pubmed: 15474877

Colin-Ramirez E, McAlister FA, Zheng Y, Sharma S, Armstrong PW, Ezekowitz JA (2015) The long-term effects of dietary sodium restriction on clinical outcomes in patients with heart failure. The SODIUM-HF (study of dietary intervention under 100 mmol in heart failure): a pilot study. Am Heart J 169:274-281.e1. https://doi.org/10.1016/j.ahj.2014.11.013

doi: 10.1016/j.ahj.2014.11.013 pubmed: 25641537

Philipson H, Ekman I, Swedberg K, Schaufelberger M (2010) A pilot study of salt and water restriction in patients with chronic heart failure. Scand Cardiovasc J 44:209–214. https://doi.org/10.3109/14017431003698523

doi: 10.3109/14017431003698523 pubmed: 20636228

Philipson H, Ekman I, Forslund HB, Swedberg K, Schaufelberger M (2013) Salt and fluid restriction is effective in patients with chronic heart failure. European J of Heart Fail 15:1304–1310. https://doi.org/10.1093/eurjhf/hft097

doi: 10.1093/eurjhf/hft097

Machado d’Almeida KS, Rabelo-Silva ER, Souza GC, Trojahn MM, Santin Barilli SL, Aliti G, Rohde LE, Biolo A, Beck-da-Silva L (2018) Aggressive fluid and sodium restriction in decompensated heart failure with preserved ejection fraction: results from a randomized clinical trial. Nutrition 54:111–117. https://doi.org/10.1016/j.nut.2018.02.007

doi: 10.1016/j.nut.2018.02.007 pubmed: 29793053

Li J, Zhen Z, Huang P, Dong Y-G, Liu C, Liang W (2022) Salt restriction and risk of adverse outcomes in heart failure with preserved ejection fraction. Heart 108:1377–1382. https://doi.org/10.1136/heartjnl-2022-321167

doi: 10.1136/heartjnl-2022-321167 pubmed: 35851318

Pitt B, Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Harty B, Heitner JF, Kenwood CT, Lewis EF, O’Meara E, Probstfield JL, Shaburishvili T, Shah SJ, Solomon SD, Sweitzer NK, Yang S, McKinlay SM (2014) Spironolactone for heart failure with preserved ejection fraction. N Engl J Med 370:1383–1392. https://doi.org/10.1056/NEJMoa1313731

doi: 10.1056/NEJMoa1313731 pubmed: 24716680

Brosolo G, Da Porto A, Marcante S, Picci A, Capilupi F, Capilupi P, Bertin N, Vivarelli C, Bulfone L, Vacca A, Catena C, Sechi LA (2023) Omega-3 fatty acids in arterial hypertension: is there any good news? IJMS 24:9520. https://doi.org/10.3390/ijms24119520

doi: 10.3390/ijms24119520 pubmed: 37298468 pmcid: 10253816

Chen X, Gu J, Huang Y (2023) High dietary intake of unsaturated fatty acids is associated with improved insulin resistance–a cross-sectional study based on the NHANES database. Lipids Health Dis 22:216. https://doi.org/10.1186/s12944-023-01982-1

doi: 10.1186/s12944-023-01982-1 pubmed: 38053162 pmcid: 10696799

Talbot NA, Wheeler-Jones CP, Cleasby ME (2014) Palmitoleic acid prevents palmitic acid-induced macrophage activation and consequent p38 MAPK-mediated skeletal muscle insulin resistance. Mol Cell Endocrinol 393:129–142. https://doi.org/10.1016/j.mce.2014.06.010

doi: 10.1016/j.mce.2014.06.010 pubmed: 24973767 pmcid: 4148479

Sun Y, Wang J, Guo X, Zhu N, Niu L, Ding X, Xie Z, Chen X, Yang F (2021) Oleic acid and eicosapentaenoic acid reverse palmitic acid-induced insulin resistance in human HepG2 cells via the reactive oxygen species/JUN pathway. Genomics Proteomics Bioinforma 19:754–771. https://doi.org/10.1016/j.gpb.2019.06.005

doi: 10.1016/j.gpb.2019.06.005

Guriec N, Le Foll C, Delarue J (2023) Long-chain n-3 PUFA given before and throughout gestation and lactation in rats prevent high-fat diet-induced insulin resistance in male offspring in a tissue-specific manner. Br J Nutr 130:1121–1136. https://doi.org/10.1017/S000711452300017X

doi: 10.1017/S000711452300017X pubmed: 36688295

Cavaliere G, Trinchese G, Bergamo P, De Filippo C, Mattace Raso G, Gifuni G, Putti R, Moni BH, Canani RB, Meli R, Mollica MP (2016) Polyunsaturated fatty acids attenuate diet induced obesity and insulin resistance, modulating mitochondrial respiratory uncoupling in rat skeletal muscle. PLoS ONE 11:e0149033. https://doi.org/10.1371/journal.pone.0149033

doi: 10.1371/journal.pone.0149033 pubmed: 26901315 pmcid: 4762694

Carbone S, Billingsley HE, Canada JM, Kadariya D, Medina De Chazal H, Rotelli B, Potere N, Paudel B, Markley R, Dixon DL, Trankle CR, Van Tassell BW, Celi FS, Abbate A (2019) Unsaturated fatty acids to improve cardiorespiratory fitness in patients with obesity and HFpEF. JACC: Basic Transl Sci 4:563–565. https://doi.org/10.1016/j.jacbts.2019.04.001

Kleissl-Muir S, Owen A, Rasmussen B, Zinn C, Driscoll A (2023) Effects of a low carbohydrate diet on heart failure symptoms and quality of life in patients with diabetic cardiomyopathy: a randomised controlled trial pilot study. Nutr Metab Cardiovasc Dis 33:2455–2463. https://doi.org/10.1016/j.numecd.2023.08.015

doi: 10.1016/j.numecd.2023.08.015 pubmed: 37798235

Kleissl-Muir S, Rasmussen B, Owen A, Zinn C, Driscoll A (2022) Low carbohydrate diets for diabetic cardiomyopathy: a hypothesis. Front Nutr 9:865489. https://doi.org/10.3389/fnut.2022.865489

doi: 10.3389/fnut.2022.865489 pubmed: 35529461 pmcid: 9069235

Jonasson L, Guldbrand H, Lundberg AK, Nystrom FH (2014) Advice to follow a low-carbohydrate diet has a favourable impact on low-grade inflammation in type 2 diabetes compared with advice to follow a low-fat diet. Ann Med 46:182–187. https://doi.org/10.3109/07853890.2014.894286

doi: 10.3109/07853890.2014.894286 pubmed: 24779961

González-Islas D, Orea-Tejeda A, Orea-Tejeda A, Castillo-Martínez L, Castillo-Martínez L, Olvera-Mayorga G, Olvera-Mayorga G, Rodríguez-García WD, Rodríguez-García WD, Santillán-Díaz C, Santillán-Díaz C, Keirnes-Davis C, Keirnes-Davis C, Vaquero-Barbosa N, Vaquero-Barbosa N (2017) The effects of a low-carbohydrate diet on oxygen saturation in heart failure patients: a randomized controlled clinical trial. Nutr Hosp 34. https://doi.org/10.20960/nh.784

Forsyth F, Mulrennan S, Burt J, Hartley P, Kuhn I, Lin H, Mant J, Tan S, Zhang R, Deaton C (2023) What dietary interventions have been tested in heart failure with preserved ejection fraction? A systematic scoping review. Eur J Cardiovasc Nurs 22:126–140. https://doi.org/10.1093/eurjcn/zvac062

doi: 10.1093/eurjcn/zvac062 pubmed: 35816028

Forte M, Rodolico D, Ameri P, Catalucci D, Chimenti C, Crotti L, Schirone L, Pingitore A, Torella D, Iacovone G, Valenti V, Schiattarella GG, Perrino C, Sciarretta S (2023) Molecular mechanisms underlying the beneficial effects of exercise and dietary interventions in the prevention of cardiometabolic diseases. J Cardiovasc Med 24:e3–e14. https://doi.org/10.2459/JCM.0000000000001397

doi: 10.2459/JCM.0000000000001397

Johnson ML, Distelmaier K, Lanza IR, Irving BA, Robinson MM, Konopka AR, Shulman GI, Nair KS (2016) Mechanism by which caloric restriction improves insulin sensitivity in sedentary obese adults. Diabetes 65:74–84. https://doi.org/10.2337/db15-0675

doi: 10.2337/db15-0675 pubmed: 26324180

Park CY, Park S, Kim MS, Kim H-K, Han SN (2017) Effects of mild calorie restriction on lipid metabolism and inflammation in liver and adipose tissue. Biochem Biophys Res Commun 490:636–642. https://doi.org/10.1016/j.bbrc.2017.06.090

doi: 10.1016/j.bbrc.2017.06.090 pubmed: 28630003

Kitzman DW, Brubaker P, Morgan T, Haykowsky M, Hundley G, Kraus WE, Eggebeen J, Nicklas BJ (2016) Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: a randomized clinical trial. JAMA 315:36. https://doi.org/10.1001/jama.2015.17346

doi: 10.1001/jama.2015.17346 pubmed: 26746456 pmcid: 4787295

Cocco G, Chu D (2007) Weight reduction decreases NT-proBNP levels in obsese coronary patients with chronic diastolic heart failure. Arch Med Sci 3:112–116

Yang L, Licastro D, Cava E, Veronese N, Spelta F, Rizza W, Bertozzi B, Villareal DT, Hotamisligil GS, Holloszy JO, Fontana L (2016) Long-term calorie restriction enhances cellular quality-control processes in human skeletal muscle. Cell Rep 14:422–428. https://doi.org/10.1016/j.celrep.2015.12.042

doi: 10.1016/j.celrep.2015.12.042 pubmed: 26774472

Espino-Gonzalez E, Tickle PG, Altara R, Gallagher H, Cheng CW, Engman V, Wood N, Justo Da Silva GJ, Scalabrin M, Yu X, Zhong Z, Colman MA, Yuldasheva NY, Booz GW, Adams V, Pereira MG, Cataliotti A, Roberts LD, Egginton S, Bowen TS (2024) Caloric restriction rejuvenates skeletal muscle growth in heart failure with preserved ejection fraction. JACC: Basic to Translational Science 9:223–240. https://doi.org/10.1016/j.jacbts.2023.09.014

Moro T, Tinsley G, Bianco A, Marcolin G, Pacelli QF, Battaglia G, Palma A, Gentil P, Neri M, Paoli A (2016) Effects of eight weeks of time-restricted feeding (16/8) on basal metabolism, maximal strength, body composition, inflammation, and cardiovascular risk factors in resistance-trained males. J Transl Med 14:290. https://doi.org/10.1186/s12967-016-1044-0

doi: 10.1186/s12967-016-1044-0 pubmed: 27737674 pmcid: 5064803

Wilkinson MJ, Manoogian ENC, Zadourian A, Lo H, Fakhouri S, Shoghi A, Wang X, Fleischer JG, Navlakha S, Panda S, Taub PR (2020) Ten-hour time-restricted eating reduces weight, blood pressure, and atherogenic lipids in patients with metabolic syndrome. Cell Metab 31:92-104.e5. https://doi.org/10.1016/j.cmet.2019.11.004

doi: 10.1016/j.cmet.2019.11.004 pubmed: 31813824

Ulgherait M, Midoun AM, Park SJ, Gatto JA, Tener SJ, Siewert J, Klickstein N, Canman JC, Ja WW, Shirasu-Hiza M (2021) Circadian autophagy drives iTRF-mediated longevity. Nature 598:353–358. https://doi.org/10.1038/s41586-021-03934-0

doi: 10.1038/s41586-021-03934-0 pubmed: 34588695 pmcid: 9395244

Evangelista LS, Jose MM, Sallam H, Serag H, Golovko G, Khanipov K, Hamilton MA, Fonarow GC (2021) High-protein vs. standard-protein diets in overweight and obese patients with heart failure and diabetes mellitus: findings of the Pro-HEART trial. ESC Heart Failure 8:1342–1348. https://doi.org/10.1002/ehf2.13213

doi: 10.1002/ehf2.13213 pubmed: 33502122 pmcid: 8006643

Tong D, Hill JA (2017) Spermidine promotes cardioprotective autophagy. Circ Res 120:1229–1231. https://doi.org/10.1161/CIRCRESAHA.117.310603

doi: 10.1161/CIRCRESAHA.117.310603 pubmed: 28408448 pmcid: 5411858

Minois N, Carmona-Gutierrez D, Bauer MA, Rockenfeller P, Eisenberg T, Brandhorst S, Sigrist SJ, Kroemer G, Madeo F (2012) Spermidine promotes stress resistance in Drosophila melanogaster through autophagy-dependent and -independent pathways. Cell Death Dis 3:e401–e401. https://doi.org/10.1038/cddis.2012.139

doi: 10.1038/cddis.2012.139 pubmed: 23059820 pmcid: 3481127

Wang J, Li S, Wang J, Wu F, Chen Y, Zhang H, Guo Y, Lin Y, Li L, Yu X, Liu T, Zhao Y (2020) Spermidine alleviates cardiac aging by improving mitochondrial biogenesis and function. Aging 12:650–671. https://doi.org/10.18632/aging.102647

doi: 10.18632/aging.102647 pubmed: 31907336 pmcid: 6977682

Ni Y-Q, Liu Y-S (2021) New insights into the roles and mechanisms of spermidine in aging and age-related diseases. Aging and disease 12:1948. https://doi.org/10.14336/AD.2021.0603

doi: 10.14336/AD.2021.0603 pubmed: 34881079 pmcid: 8612618

Liu R, Li X, Ma H, Yang Q, Shang Q, Song L, Zheng Z, Zhang S, Pan Y, Huang P, Fang J, Li Y, Liu Z, Cao L, Feng C, Gong Z, Chen Y, Wang Y, Melino G, Shao C, Shi Y (2020) Spermidine endows macrophages anti-inflammatory properties by inducing mitochondrial superoxide-dependent AMPK activation, Hif-1α upregulation and autophagy. Free Radical Biol Med 161:339–350. https://doi.org/10.1016/j.freeradbiomed.2020.10.029

doi: 10.1016/j.freeradbiomed.2020.10.029

Lv F, Zhang J, Tao Y (2023) Efficacy and safety of inorganic nitrate/nitrite supplementary therapy in heart failure with preserved ejection fraction. Front Cardiovasc Med 10:1054666. https://doi.org/10.3389/fcvm.2023.1054666

doi: 10.3389/fcvm.2023.1054666 pubmed: 36818337 pmcid: 9932197

Qin L, Wang S (2022) Protective roles of inorganic nitrate in health and diseases. Curr Med 1:4. https://doi.org/10.1007/s44194-022-00002-1

doi: 10.1007/s44194-022-00002-1

Borlaug BA, Koepp KE, Reddy YNV, Obokata M, Sorimachi H, Freund M, Haberman D, Sweere K, Weber KL, Overholt EA, Safe BA, Omote K, Omar M, Popovic D, Acker NG, Gladwin MT, Olson TP, Carter RE (2024) Inorganic nitrite to amplify the benefits and tolerability of exercise training in heart failure with preserved ejection fraction: the INABLE-training trial. Mayo Clin Proc 99:206–217. https://doi.org/10.1016/j.mayocp.2023.08.031

doi: 10.1016/j.mayocp.2023.08.031 pubmed: 38127015

Selvaraj S, Bhatt DL, Steg PhG, Miller M, Brinton EA, Jacobson TA, Juliano RA, Jiao L, Tardif J, Ballantyne CM, the REDUCE‐IT Investigators (2022) Impact of icosapent ethyl on cardiovascular risk reduction in patients with heart failure in REDUCE‐IT. JAHA 11:e024999. https://doi.org/10.1161/JAHA.121.024999

Huynh K, Kiriazis H, Du X-J, Love JE, Jandeleit-Dahm KA, Forbes JM, McMullen JR, Ritchie RH (2012) Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes. Diabetologia 55:1544–1553. https://doi.org/10.1007/s00125-012-2495-3

doi: 10.1007/s00125-012-2495-3 pubmed: 22374176

Farsi F, Mohammadshahi M, Alavinejad P, Rezazadeh A, Zarei M, Engali KA (2016) Functions of coenzyme Q10 supplementation on liver enzymes, markers of systemic inflammation, and adipokines in patients affected by nonalcoholic fatty liver disease: a double-blind, placebo-controlled, randomized clinical trial. J Am Coll Nutr 35:346–353. https://doi.org/10.1080/07315724.2015.1021057

doi: 10.1080/07315724.2015.1021057 pubmed: 26156412

Mortensen SA, Rosenfeldt F, Kumar A, Dolliner P, Filipiak KJ, Pella D, Alehagen U, Steurer G, Littarru GP (2014) The effect of coenzyme Q 10 on morbidity and mortality in chronic heart failure. JACC: Heart Failure 2:641–649. https://doi.org/10.1016/j.jchf.2014.06.008

Sobirin MA, Herry Y, Sofia SN, Uddin I, Rifqi S, Tsutsui H (2019) Effects of coenzyme Q10 supplementation on diastolic function in patients with heart failure with preserved ejection fraction. DD&T 13:38–46. https://doi.org/10.5582/ddt.2019.01004

doi: 10.5582/ddt.2019.01004

Pierce JD, Shen Q, Mahoney DE, Rahman F, Krueger KJ, Diaz FJ, Clark L, Smith C, Vacek J, Hiebert JB (2022) Effects of ubiquinol and/or D-ribose in patients with heart failure with preserved ejection fraction. Am J Cardiol 176:79–88. https://doi.org/10.1016/j.amjcard.2022.04.031

doi: 10.1016/j.amjcard.2022.04.031 pubmed: 35644694 pmcid: 9576187

Samuel TY, Hasin T, Gotsman I, Weitzman T, Ben Ivgi F, Dadon Z, Asher E, Amir O, Glikson M, Alcalai R, Leibowitz D (2022) Coenzyme Q10 in the treatment of heart failure with preserved ejection fraction: a prospective, randomized, double-blind, placebo-controlled trial. Drugs R D 22:25–33. https://doi.org/10.1007/s40268-021-00372-1

doi: 10.1007/s40268-021-00372-1 pubmed: 34826125

Vaz FM, Wanders RJA (2002) Carnitine biosynthesis in mammals. Biochem J 361:417–429. https://doi.org/10.1042/bj3610417

doi: 10.1042/bj3610417 pubmed: 11802770 pmcid: 1222323

Soukoulis V, Dihu JB, Sole M, Anker SD, Cleland J, Fonarow GC, Metra M, Pasini E, Strzelczyk T, Taegtmeyer H, Gheorghiade M (2009) Micronutrient deficiencies: an unmet need in heart failure. J Am Coll Cardiol 54:1660–1673. https://doi.org/10.1016/j.jacc.2009.08.012

doi: 10.1016/j.jacc.2009.08.012 pubmed: 19850206

Omori Y, Mano T, Sakata Y, Ohtani T, Takeda Y, Tamaki S, Kamimura D, Tsukamoto Y, Aizawa Y, Ikeya Y, Miwa T, Soga T, Yamamoto K, Komuro I (2011) L-carnitine supplementation as treatment for cardiac fibrosis and heart failure with preserved ejection fraction. J Cardiac Fail 17:S154. https://doi.org/10.1016/j.cardfail.2011.06.504

doi: 10.1016/j.cardfail.2011.06.504

Askarpour M, Hadi A, Miraghajani M, Symonds ME, Sheikhi A, Ghaedi E (2020) Beneficial effects of l-carnitine supplementation for weight management in overweight and obese adults: an updated systematic review and dose-response meta-analysis of randomized controlled trials. Pharmacol Res 151:104554. https://doi.org/10.1016/j.phrs.2019.104554

doi: 10.1016/j.phrs.2019.104554 pubmed: 31743774

Emran T, Chowdhury NI, Sarker M, Bepari AK, Hossain M, Rahman GMS, Reza HM (2021) L-carnitine protects cardiac damage by reducing oxidative stress and inflammatory response via inhibition of tumor necrosis factor-alpha and interleukin-1beta against isoproterenol-induced myocardial infarction. Biomed Pharmacother 143:112139. https://doi.org/10.1016/j.biopha.2021.112139

doi: 10.1016/j.biopha.2021.112139 pubmed: 34507121

Kinugasa Y, Sota T, Ishiga N, Nakamura K, Kamitani H, Hirai M, Yanagihara K, Kato M, Yamamoto K (2020) L-Carnitine supplementation in heart failure patients with preserved ejection fraction; a pilot study. Geriatrics Gerontology Int 20:1244–1245. https://doi.org/10.1111/ggi.14060

doi: 10.1111/ggi.14060

Nolte K, Herrmann-Lingen C, Platschek L, Holzendorf V, Pilz S, Tomaschitz A, Düngen H, Angermann CE, Hasenfuß G, Pieske B, Wachter R, Edelmann F (2019) Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction. ESC Heart Failure 6:262–270. https://doi.org/10.1002/ehf2.12413

doi: 10.1002/ehf2.12413 pubmed: 30784226 pmcid: 6437442

Brosolo G, Da Porto A, Bulfone L, Scandolin L, Vacca A, Bertin N, Vivarelli C, Sechi LA, Catena C (2022) Vitamin D deficiency is associated with glycometabolic changes in nondiabetic patients with arterial hypertension. Nutrients 14:311. https://doi.org/10.3390/nu14020311

doi: 10.3390/nu14020311 pubmed: 35057492 pmcid: 8778458

Fallo F, Catena C, Camozzi V, Luisetto G, Cosma C, Plebani M, Lupia M, Tona F, Sechi LA (2012) Low serum 25-hydroxyvitamin D levels are associated with left ventricular hypertrophy in essential hypertension. Nutr Metab Cardiovasc Dis 22:871–876. https://doi.org/10.1016/j.numecd.2011.06.001

doi: 10.1016/j.numecd.2011.06.001 pubmed: 21937207

Lee JH, O’Keefe JH, Bell D, Hensrud DD, Holick MF (2008) Vitamin D deficiency. J Am Coll Cardiol 52:1949–1956. https://doi.org/10.1016/j.jacc.2008.08.050

doi: 10.1016/j.jacc.2008.08.050 pubmed: 19055985

Bouillon R, Carmeliet G, Verlinden L, Van Etten E, Verstuyf A, Luderer HF, Lieben L, Mathieu C, Demay M (2008) Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 29:726–776. https://doi.org/10.1210/er.2008-0004

doi: 10.1210/er.2008-0004 pubmed: 18694980 pmcid: 2583388

Mirhosseini N, Vatanparast H, Mazidi M, Kimball SM (2018) Vitamin D supplementation, glycemic control, and insulin resistance in prediabetics: a meta-analysis. Journal of the Endocrine Society 2:687–709. https://doi.org/10.1210/js.2017-00472

doi: 10.1210/js.2017-00472 pubmed: 29951596 pmcid: 6016617

AlGhamdi SA, Enaibsi NN, Alsufiani HM, Alshaibi HF, Khoja SO, Carlberg C (2022) A single oral vitamin D3 bolus reduces inflammatory markers in healthy Saudi males. IJMS 23:11992. https://doi.org/10.3390/ijms231911992

doi: 10.3390/ijms231911992 pubmed: 36233290 pmcid: 9569869

Boxer RS, Kenny AM, Schmotzer BJ, Vest M, Fiutem JJ, Piña IL (2013) A randomized controlled trial of high-dose vitamin D 3 in patients with heart failure. JACC: Heart Failure 1:84–90. https://doi.org/10.1016/j.jchf.2012.11.003

Brosolo G, Da Porto A, Bulfone L, Vacca A, Bertin N, Catena C, Sechi LA (2023) Cortisol secretion and abnormalities of glucose metabolism in nondiabetic patients with hypertension. J Hypertens. https://doi.org/10.1097/HJH.0000000000003590

doi: 10.1097/HJH.0000000000003590 pubmed: 37796203

Brosolo G, Catena C, Da Porto A, Bulfone L, Vacca A, Verheyen ND, Sechi LA (2022) Differences in regulation of cortisol secretion contribute to left ventricular abnormalities in patients with essential hypertension. Hypertension 79:1435–1444. https://doi.org/10.1161/HYPERTENSIONAHA.122.19472

doi: 10.1161/HYPERTENSIONAHA.122.19472 pubmed: 35535606

Thesing CS, Bot M, Milaneschi Y, Giltay EJ, Penninx BWJH (2018) Omega-3 polyunsaturated fatty acid levels and dysregulations in biological stress systems. Psychoneuroendocrinology 97:206–215. https://doi.org/10.1016/j.psyneuen.2018.07.002

doi: 10.1016/j.psyneuen.2018.07.002 pubmed: 30077075

Chen J, Shearer GC, Chen Q, Healy CL, Beyer AJ, Nareddy VB, Gerdes AM, Harris WS, O’Connell TD, Wang D (2011) Omega-3 fatty acids prevent pressure overload–induced cardiac fibrosis through activation of cyclic GMP/protein kinase g signaling in cardiac fibroblasts. Circulation 123:584–593. https://doi.org/10.1161/CIRCULATIONAHA.110.971853

doi: 10.1161/CIRCULATIONAHA.110.971853 pubmed: 21282499 pmcid: 3056077

Block RC, Liu L, Herrington DM, Huang S, Tsai MY, O’Connell TD, Shearer GC (2019) Predicting risk for incident heart failure with omega-3 fatty acids. JACC: Heart Failure 7:651–661. https://doi.org/10.1016/j.jchf.2019.03.008

Matsuo N, Miyoshi T, Takaishi A, Kishinoue T, Yasuhara K, Tanimoto M, Nakano Y, Onishi N, Ueeda M, Ito H (2021) High plasma docosahexaenoic acid associated to better prognoses of patients with acute decompensated heart failure with preserved ejection fraction. Nutrients 13:371. https://doi.org/10.3390/nu13020371

doi: 10.3390/nu13020371 pubmed: 33530352 pmcid: 7911271

Tavazzi L, Maggioni AP, Marchioli R, Barlera S (2008) Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. The Lancet 372:1223–1230. https://doi.org/10.1016/S0140-6736(08)61239-8

doi: 10.1016/S0140-6736(08)61239-8

Jiang W, Whellan DJ, Adams KF, Babyak MA, Boyle SH, Wilson JL, Patel CB, Rogers JG, Harris WS, O’Connor CM (2018) Long-chain omega-3 fatty acid supplements in depressed heart failure patients. JACC: Heart Failure 6:833–843. https://doi.org/10.1016/j.jchf.2018.03.011

Azhar G, Raza S, Pangle A, Coleman K, Dawson A, Schrader A, Wolfe RR, Wei JY (2020) Potential beneficial effects of dietary protein supplementation and exercise on functional capacity in a pilot study of individuals with heart failure with preserved ejection fraction. Gerontology and Geriatric Medicine 6:233372142098280. https://doi.org/10.1177/2333721420982808

doi: 10.1177/2333721420982808

Pineda-Juárez JA, Sánchez-Ortiz NA, Castillo-Martínez L, Orea-Tejeda A, Cervantes-Gaytán R, Keirns-Davis C, Pérez-Ocampo C, Quiroz-Bautista K, Tenorio-Dupont M, Ronquillo-Martínez A (2016) Changes in body composition in heart failure patients after a resistance exercise program and branched chain amino acid supplementation. Clin Nutr 35:41–47. https://doi.org/10.1016/j.clnu.2015.02.004

doi: 10.1016/j.clnu.2015.02.004 pubmed: 25726428

Rennie MJ, Bohé J, Smith K, Wackerhage H, Greenhaff P (2006) Branched-chain amino acids as fuels and anabolic signals in human muscle. J Nutr 136:264S-268S. https://doi.org/10.1093/jn/136.1.264S

doi: 10.1093/jn/136.1.264S pubmed: 16365095

Hummel SL, Karmally W, Gillespie BW, Helmke S, Teruya S, Wells J, Trumble E, Jimenez O, Marolt C, Wessler JD, Cornellier ML, Maurer MS (2018) Home-delivered meals postdischarge from heart failure hospitalization: the GOURMET-HF pilot study. Circ: Heart Failure 11:e004886. https://doi.org/10.1161/CIRCHEARTFAILURE.117.004886

Hummel SL, Seymour EM, Brook RD, Kolias TJ, Sheth SS, Rosenblum HR, Wells JM, Weder AB (2012) Low-sodium dietary approaches to stop hypertension diet reduces blood pressure, arterial stiffness, and oxidative stress in hypertensive heart failure with preserved ejection fraction. Hypertension 60:1200–1206. https://doi.org/10.1161/HYPERTENSIONAHA.112.202705

doi: 10.1161/HYPERTENSIONAHA.112.202705 pubmed: 23033371

Hummel SL, Seymour EM, Brook RD, Sheth SS, Ghosh E, Zhu S, Weder AB, Kovács SJ, Kolias TJ (2013) Low-sodium DASH diet improves diastolic function and ventricular–arterial coupling in hypertensive heart failure with preserved ejection fraction. Circ: Heart Failure 6:1165–1171. https://doi.org/10.1161/CIRCHEARTFAILURE.113.000481

Hammer S, Snel M, Lamb HJ, Jazet IM, Van Der Meer RW, Pijl H, Meinders EA, Romijn JA, De Roos A, Smit JWA (2008) Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function. J Am Coll Cardiol 52:1006–1012. https://doi.org/10.1016/j.jacc.2008.04.068

doi: 10.1016/j.jacc.2008.04.068 pubmed: 18786482

Gulsin GS, Swarbrick DJ, Athithan L, Brady EM, Henson J, Baldry E, Argyridou S, Jaicim NB, Squire G, Walters Y, Marsh A-M, McAdam J, Parke KS, Biglands JD, Yates T, Khunti K, Davies MJ, McCann GP (2020) Effects of low-energy diet or exercise on cardiovascular function in working-age adults with type 2 diabetes: a prospective, randomized, open-label, blinded end point trial. Diabetes Care 43:1300–1310. https://doi.org/10.2337/dc20-0129

doi: 10.2337/dc20-0129 pubmed: 32220917

Lean MEJ, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, Peters C, Zhyzhneuskaya S, Al-Mrabeh A, Hollingsworth KG, Rodrigues AM, Rehackova L, Adamson AJ, Sniehotta FF, Mathers JC, Ross HM, McIlvenna Y, Welsh P, Kean S, Ford I, McConnachie A, Messow C-M, Sattar N, Taylor R (2019) Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes Endocrinol 7:344–355. https://doi.org/10.1016/S2213-8587(19)30068-3

doi: 10.1016/S2213-8587(19)30068-3 pubmed: 30852132

Nordmann AJ, Nordmann A, Briel M, Keller U, Yancy WS, Brehm BJ, Bucher HC (2006) Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Intern Med 166:285. https://doi.org/10.1001/archinte.166.3.285

doi: 10.1001/archinte.166.3.285 pubmed: 16476868

Deng Y, Xie M, Li Q, Xu X, Ou W, Zhang Y, Xiao H, Yu H, Zheng Y, Liang Y, Jiang C, Chen G, Du D, Zheng W, Wang S, Gong M, Chen Y, Tian R, Li T (2021) Targeting mitochondria-inflammation circuit by β-hydroxybutyrate mitigates HFpEF. Circ Res 128:232–245. https://doi.org/10.1161/CIRCRESAHA.120.317933

doi: 10.1161/CIRCRESAHA.120.317933 pubmed: 33176578

Nielsen R, Møller N, Gormsen LC, Tolbod LP, Hansson NH, Sorensen J, Harms HJ, Frøkiær J, Eiskjaer H, Jespersen NR, Mellemkjaer S, Lassen TR, Pryds K, Bøtker HE, Wiggers H (2019) Cardiovascular effects of treatment with the ketone body 3-hydroxybutyrate in chronic heart failure patients. Circulation 139:2129–2141. https://doi.org/10.1161/CIRCULATIONAHA.118.036459

doi: 10.1161/CIRCULATIONAHA.118.036459 pubmed: 30884964 pmcid: 6493702

Lopaschuk GD, Dyck JRB (2023) Ketones and the cardiovascular system. Nat Cardiovasc Res 2:425–437. https://doi.org/10.1038/s44161-023-00259-1

doi: 10.1038/s44161-023-00259-1 pubmed: 39196044

Finicelli M, Di Salle A, Galderisi U, Peluso G (2022) The Mediterranean diet: an update of the clinical trials. Nutrients 14:2956. https://doi.org/10.3390/nu14142956

doi: 10.3390/nu14142956 pubmed: 35889911 pmcid: 9317652

Sanderson JE (2017) Alcohol, hypertension, and heart failure with preserved (or normal) ejection fraction. Eur Heart J Qual Care Clin Outcomes 3:93–93. https://doi.org/10.1093/ehjqcco/qcw042

doi: 10.1093/ehjqcco/qcw042 pubmed: 28927192

Vacca A, Bulfone L, Cicco S, Brosolo G, Da Porto A, Soardo G, Catena C, Sechi LA (2023) Alcohol intake and arterial hypertension: retelling of a multifaceted story. Nutrients 15:958. https://doi.org/10.3390/nu15040958

doi: 10.3390/nu15040958 pubmed: 36839317 pmcid: 9963590

Miró Ò, Estruch R, Martín-Sánchez FJ, Gil V, Jacob J, Herrero-Puente P, Herrera Mateo S, Aguirre A, Andueza JA, Llorens P, Alonso H, Fuentes M, Gil C, Pérez-Durá MJ, Salvo E, Escoda R, Xipell C, Sánchez C, Gaytan JM, Noval A, Torres JM, López-Grima ML, Juan MA, Valero A, Pedragosa MÀ, Alonso MI, Ruiz F, Romero R, Calvache R, Morante C, Lorca MT, Mecina AB, Tost J, De La Fuente Penco B, López Sánchez A, Sánchez S, Piñera P, Garate RT, Alquézar A, Rizzi MA, Richard F, Álvarez Pérez JM, López Diez MP, Lucas J, Roset Á, Rodríguez-Adrada E, Llopis García G, Garrido JM, Fernández-Cañadas JM, Marquina V, Jiménez I, Javaloyes P, Vázquez Alvarez J, Alonso Morilla A, Irimia A (2018) Adherence to Mediterranean diet and all-cause mortality after an episode of acute heart failure. JACC: Heart Failure 6:52–62. https://doi.org/10.1016/j.jchf.2017.09.020

doi: 10.1016/j.jchf.2017.09.020 pubmed: 29226819

Casas R, Sacanella E, Urpí-Sardà M, Chiva-Blanch G, Ros E, Martínez-González M-A, Covas M-I, Lamuela-Raventos RM, Salas-Salvadó J, Fiol M, Arós F, Estruch R (2014) The effects of the Mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects with high risk for cardiovascular disease. A randomized trial PLoS ONE 9:e100084. https://doi.org/10.1371/journal.pone.0100084

doi: 10.1371/journal.pone.0100084 pubmed: 24925270

Fitó M, Estruch R, Salas‐Salvadó J, Martínez‐Gonzalez MA, Arós F, Vila J, Corella D, Díaz O, Sáez G, De La Torre R, Mitjavila M, Muñoz MA, Lamuela‐Raventós R, Ruiz‐Gutierrez V, Fiol M, Gómez‐Gracia E, Lapetra J, Ros E, Serra‐Majem L, Covas M, on behalf of the PREDIMED Study Investigators (2014) Effect of the Mediterranean diet on heart failure biomarkers: a randomized sample from the PREDIMED trial. European J of Heart Fail 16:543–550. https://doi.org/10.1002/ejhf.61

Kouvari M, Chrysohoou C, Aggelopoulos P, Tsiamis E, Tsioufis K, Pitsavos C, Tousoulis D (2017) Mediterranean diet and prognosis of first-diagnosed acute coronary syndrome patients according to heart failure phenotype: hellenic heart failure study. Eur J Clin Nutr 71:1321–1328. https://doi.org/10.1038/ejcn.2017.122

doi: 10.1038/ejcn.2017.122

Wang T, Masedunskas A, Willett WC, Fontana L (2023) Vegetarian and vegan diets: benefits and drawbacks. Eur Heart J 44:3423–3439. https://doi.org/10.1093/eurheartj/ehad436

doi: 10.1093/eurheartj/ehad436 pubmed: 37450568 pmcid: 10516628

Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW (2022) 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 145. https://doi.org/10.1161/CIR.0000000000001063

Pandey A, LaMonte M, Klein L, Ayers C, Psaty BM, Eaton CB, Allen NB, De Lemos JA, Carnethon M, Greenland P, Berry JD (2017) Relationship between physical activity, body mass index, and risk of heart failure. J Am Coll Cardiol 69:1129–1142. https://doi.org/10.1016/j.jacc.2016.11.081

doi: 10.1016/j.jacc.2016.11.081 pubmed: 28254175 pmcid: 5848099

Edelmann F, Gelbrich G, Düngen H-D, Fröhling S, Wachter R, Stahrenberg R, Binder L, Töpper A, Lashki DJ, Schwarz S, Herrmann-Lingen C, Löffler M, Hasenfuss G, Halle M, Pieske B (2011) Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction. J Am Coll Cardiol 58:1780–1791. https://doi.org/10.1016/j.jacc.2011.06.054

doi: 10.1016/j.jacc.2011.06.054 pubmed: 21996391

Angadi SS, Mookadam F, Lee CD, Tucker WJ, Haykowsky MJ, Gaesser GA (2015) High-intensity interval training vs. moderate-intensity continuous exercise training in heart failure with preserved ejection fraction: a pilot study. J Appl Physiol 119:753–758. https://doi.org/10.1152/japplphysiol.00518.2014

doi: 10.1152/japplphysiol.00518.2014 pubmed: 25190739

Donelli Da Silveira A, Beust De Lima J, Da Silva PD, Dos Santos MD, Zanini M, Nery R, Laukkanen JA, Stein R (2020) High-intensity interval training is effective and superior to moderate continuous training in patients with heart failure with preserved ejection fraction: a randomized clinical trial. Eur J Prev Cardiolog 27:1733–1743. https://doi.org/10.1177/2047487319901206

doi: 10.1177/2047487319901206

Lang CC, Smith K, Wingham J, Eyre V, Greaves CJ, Warren FC, Green C, Jolly K, Davis RC, Doherty PJ, Miles J, Britten N, Abraham C, Van Lingen R, Singh SJ, Paul K, Hillsdon M, Sadler S, Hayward C, Dalal HM, Taylor RS (2018) A randomised controlled trial of a facilitated home-based rehabilitation intervention in patients with heart failure with preserved ejection fraction and their caregivers: the REACH-HFpEF Pilot Study. BMJ Open 8:e019649. https://doi.org/10.1136/bmjopen-2017-019649

doi: 10.1136/bmjopen-2017-019649 pubmed: 29632081 pmcid: 5893929

Andryukhin A, Frolova E, Vaes B, Degryse J (2010) The impact of a nurse-led care programme on events and physical and psychosocial parameters in patients with heart failure with preserved ejection fraction: a randomized clinical trial in primary care in Russia. European J Gen Pract 16:205–214. https://doi.org/10.3109/13814788.2010.527938

doi: 10.3109/13814788.2010.527938

Pandey A, Parashar A, Kumbhani DJ, Agarwal S, Garg J, Kitzman D, Levine BD, Drazner M, Berry JD (2015) Exercise training in patients with heart failure and preserved ejection fraction: meta-analysis of randomized control trials. Circ: Heart Failure 8:33–40. https://doi.org/10.1161/CIRCHEARTFAILURE.114.001615

Guo Y, Xiao C, Zhao K, He Z, Liu S, Wu X, Shi S, Chen Z, Shi R (2022) Physical exercise modalities for the management of heart failure with preserved ejection fraction: a systematic review and meta-analysis. J Cardiovasc Pharmacol 79:698–710. https://doi.org/10.1097/FJC.0000000000001254

doi: 10.1097/FJC.0000000000001254 pubmed: 35522702 pmcid: 9067087

Shafiq A, Brawner CA, Aldred HA, Lewis B, Williams CT, Tita C, Schairer JR, Ehrman JK, Velez M, Selektor Y, Lanfear DE, Keteyian SJ (2016) Prognostic value of cardiopulmonary exercise testing in heart failure with preserved ejection fraction. The Henry Ford HospITal cardiopulmonary exercise testing (FIT-CPX) project. Am Heart J 174:167–172. https://doi.org/10.1016/j.ahj.2015.12.020

doi: 10.1016/j.ahj.2015.12.020 pubmed: 26995385 pmcid: 4804356

Sachdev V, Sharma K, Keteyian SJ, Alcain CF, Desvigne-Nickens P, Fleg JL, Florea VG, Franklin BA, Guglin M, Halle M, Leifer ES, Panjrath G, Tinsley EA, Wong RP, Kitzman DW, on behalf of the American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Arteriosclerosis, Thrombosis and Vascular Biology; and American College of Cardiology (2023) Supervised Exercise Training for Chronic Heart Failure With Preserved Ejection Fraction: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation 147:. https://doi.org/10.1161/CIR.0000000000001122

Kitzman DW (2002) Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 288:2144. https://doi.org/10.1001/jama.288.17.2144

doi: 10.1001/jama.288.17.2144 pubmed: 12413374

Nayor M, Houstis NE, Namasivayam M, Rouvina J, Hardin C, Shah RV, Ho JE, Malhotra R, Lewis GD (2020) Impaired exercise tolerance in heart failure with preserved ejection fraction. JACC: Heart Failure 8:605–617. https://doi.org/10.1016/j.jchf.2020.03.008

Upadhya B, Kitzman DW (2023) Mechanisms of exercise intolerance in chronic heart failure with preserved ejection fraction. Chest 164:574–577. https://doi.org/10.1016/j.chest.2023.06.019

doi: 10.1016/j.chest.2023.06.019 pubmed: 37689469

Lam CSP, Grewal J, Borlaug BA, Ommen SR, Kane GC, McCully RB, Pellikka PA (2010) Size, shape, and stamina: the impact of left ventricular geometry on exercise capacity. Hypertension 55:1143–1149. https://doi.org/10.1161/HYPERTENSIONAHA.109.146845

doi: 10.1161/HYPERTENSIONAHA.109.146845 pubmed: 20215563

Salzano A, De Luca M, Israr MZ, Crisci G, Eltayeb M, Debiec R, Ranieri B, D’Assante R, Rega S, D’Agostino A, Mauro C, Squire IB, Suzuki T, Bossone E, Guazzi M, Marra AM (2021) Exercise intolerance in heart failure with preserved ejection fraction. Heart Fail Clin 17:397–413. https://doi.org/10.1016/j.hfc.2021.03.004

doi: 10.1016/j.hfc.2021.03.004 pubmed: 34051972

Chien S, Lo C, Lin C, Sung K, Tsai J, Huang W, Yun C, Hung T, Lin J, Liu C, Hou CJ, Tsai I, Su C, Yeh H, Hung C (2019) Malnutrition in acute heart failure with preserved ejection fraction: clinical correlates and prognostic implications. ESC Heart Failure 6:953–964. https://doi.org/10.1002/ehf2.12501

doi: 10.1002/ehf2.12501 pubmed: 31400092 pmcid: 6816066

Mirzai S, Carbone S, Batsis JA, Kritchevsky SB, Kitzman DW, Shapiro MD (2024) Sarcopenic obesity and cardiovascular disease: an overlooked but high-risk syndrome. Curr Obes Rep. https://doi.org/10.1007/s13679-024-00571-2

doi: 10.1007/s13679-024-00571-2 pubmed: 38753289 pmcid: 11306598

Carbone S, Lavie CJ, Arena R (2017) Obesity and heart failure: focus on the obesity paradox. Mayo Clin Proc 92:266–279. https://doi.org/10.1016/j.mayocp.2016.11.001

doi: 10.1016/j.mayocp.2016.11.001 pubmed: 28109619

Middlekauff HR (2010) Making the case for skeletal myopathy as the major limitation of exercise capacity in heart failure. Circ: Heart Failure 3:537–546. https://doi.org/10.1161/CIRCHEARTFAILURE.109.903773

Haykowsky MJ, Tomczak CR, Scott JM, Paterson DI, Kitzman DW (2015) Determinants of exercise intolerance in patients with heart failure and reduced or preserved ejection fraction. J Appl Physiol 119:739–744. https://doi.org/10.1152/japplphysiol.00049.2015

doi: 10.1152/japplphysiol.00049.2015 pubmed: 25911681 pmcid: 4687865

Weiss K, Schär M, Panjrath GS, Zhang Y, Sharma K, Bottomley PA, Golozar A, Steinberg A, Gerstenblith G, Russell SD, Weiss RG (2017) Fatigability, exercise intolerance, and abnormal skeletal muscle energetics in heart failure. Circ: Heart Failure 10:e004129. https://doi.org/10.1161/CIRCHEARTFAILURE.117.004129

Kumar AA, Kelly DP, Chirinos JA (2019) Mitochondrial dysfunction in heart failure with preserved ejection fraction. Circulation 139:1435–1450. https://doi.org/10.1161/CIRCULATIONAHA.118.036259

doi: 10.1161/CIRCULATIONAHA.118.036259 pubmed: 30856000 pmcid: 6414077

Scandalis L, Kitzman DW, Nicklas BJ, Lyles M, Brubaker P, Nelson MB, Gordon M, Stone J, Bergstrom J, Neufer PD, Gnaiger E, Molina AJA (2023) Skeletal muscle mitochondrial respiration and exercise intolerance in patients with heart failure with preserved ejection fraction. JAMA Cardiol 8:575. https://doi.org/10.1001/jamacardio.2023.0957

doi: 10.1001/jamacardio.2023.0957 pubmed: 37163294 pmcid: 10173105

Zhang H, Ryu D, Wu Y, Gariani K, Wang X, Luan P, D’Amico D, Ropelle ER, Lutolf MP, Aebersold R, Schoonjans K, Menzies KJ, Auwerx J (2016) NAD

doi: 10.1126/science.aaf2693 pubmed: 27127236

Tucker WJ, Angadi SS, Haykowsky MJ, Nelson MD, Sarma S, Tomczak CR (2020) Pathophysiology of exercise intolerance and its treatment with exercise-based cardiac rehabilitation in heart failure with preserved ejection fraction. J Cardiopulm Rehabil Prev 40:9–16. https://doi.org/10.1097/HCR.0000000000000481

doi: 10.1097/HCR.0000000000000481 pubmed: 31764536 pmcid: 6928441

Kitzman DW, Brubaker PH, Herrington DM, Morgan TM, Stewart KP, Hundley WG, Abdelhamed A, Haykowsky MJ (2013) Effect of endurance exercise training on endothelial function and arterial stiffness in older patients with heart failure and preserved ejection fraction. J Am Coll Cardiol 62:584–592. https://doi.org/10.1016/j.jacc.2013.04.033

doi: 10.1016/j.jacc.2013.04.033 pubmed: 23665370 pmcid: 3740089

Pandey A, Shah SJ, Butler J, Kellogg DL, Lewis GD, Forman DE, Mentz RJ, Borlaug BA, Simon MA, Chirinos JA, Fielding RA, Volpi E, Molina AJA, Haykowsky MJ, Sam F, Goodpaster BH, Bertoni AG, Justice JN, White JP, Ding J, Hummel SL, LeBrasseur NK, Taffet GE, Pipinos II, Kitzman D (2021) Exercise intolerance in older adults with heart failure with preserved ejection fraction. J Am Coll Cardiol 78:1166–1187. https://doi.org/10.1016/j.jacc.2021.07.014

doi: 10.1016/j.jacc.2021.07.014 pubmed: 34503685 pmcid: 8525886

Kitzman DW, Haykowsky MJ, Tomczak CR (2017) Making the case for skeletal muscle myopathy and its contribution to exercise intolerance in heart failure with preserved ejection fraction. circ: heart failure 10:e004281. https://doi.org/10.1161/circheartfailure.117.004281

Haykowsky M, Brubaker P, Kitzman D (2012) Role of physical training in heart failure with preserved ejection fraction. Curr Heart Fail Rep 9:101–106. https://doi.org/10.1007/s11897-012-0087-7

doi: 10.1007/s11897-012-0087-7 pubmed: 22430146 pmcid: 4415355

Pandey A, Kitzman DW (2021) Searching for the optimal exercise training regimen in heart failure with preserved ejection fraction. JAMA 325:537. https://doi.org/10.1001/jama.2020.26347

doi: 10.1001/jama.2020.26347 pubmed: 33560307 pmcid: 8261711

Keteyian SJ, Brawner CA, Ehrman JK, Ivanhoe R, Boehmer JP, Abraham WT (2010) Reproducibility of peak oxygen uptake and other cardiopulmonary exercise parameters. Chest 138:950–955. https://doi.org/10.1378/chest.09-2624

doi: 10.1378/chest.09-2624 pubmed: 20522572

Dun Y, Smith JR, Liu S, Olson TP (2019) High-intensity interval training in cardiac rehabilitation. Clin Geriatr Med 35:469–487. https://doi.org/10.1016/j.cger.2019.07.011

doi: 10.1016/j.cger.2019.07.011 pubmed: 31543179 pmcid: 6760312

Walters GWM, Yeo JL, Bilak JM, Pepper C, Gulsin GS, Freeman SC, Gray LJ, McCANN GP, Brady EM (2024) The effectiveness of lifestyle interventions in heart failure with preserved ejection fraction: a systematic review and network meta-analysis. Journal of Cardiac Failure S1071916424000460. https://doi.org/10.1016/j.cardfail.2024.01.015

Norton K, Norton L, Sadgrove D (2010) Position statement on physical activity and exercise intensity terminology. J Sci Med Sport 13:496–502. https://doi.org/10.1016/j.jsams.2009.09.008

doi: 10.1016/j.jsams.2009.09.008 pubmed: 20005170

Trapp EG, Chisholm DJ, Freund J, Boutcher SH (2008) The effects of high-intensity intermittent exercise training on fat loss and fasting insulin levels of young women. Int J Obes 32:684–691. https://doi.org/10.1038/sj.ijo.0803781

doi: 10.1038/sj.ijo.0803781

Jelleyman C, Yates T, O’Donovan G, Gray LJ, King JA, Khunti K, Davies MJ (2015) The effects of high-intensity interval training on glucose regulation and insulin resistance: a meta-analysis. Obes Rev 16:942–961. https://doi.org/10.1111/obr.12317

doi: 10.1111/obr.12317 pubmed: 26481101

Anjos JM, Neto MG, Dos Santos FS, Almeida KDO, Bocchi EA, Lima Bitar YDS, Duraes AR (2022) The impact of high-intensity interval training on functioning and health-related quality of life in post-stroke patients: a systematic review with meta-analysis. Clin Rehabil 36:726–739. https://doi.org/10.1177/02692155221087082

doi: 10.1177/02692155221087082 pubmed: 35290104

Hwang C-L, Wu Y-T, Chou C-H (2011) Effect of aerobic interval training on exercise capacity and metabolic risk factors in people with cardiometabolic disorders: a meta-analysis. J Cardiopulm Rehabil Prev 31:378–385. https://doi.org/10.1097/HCR.0b013e31822f16cb

doi: 10.1097/HCR.0b013e31822f16cb pubmed: 21946419

Mueller S, Winzer EB, Duvinage A, Gevaert AB, Edelmann F, Haller B, Pieske-Kraigher E, Beckers P, Bobenko A, Hommel J, Van De Heyning CM, Esefeld K, Von Korn P, Christle JW, Haykowsky MJ, Linke A, Wisløff U, Adams V, Pieske B, Van Craenenbroeck EM, Halle M, OptimEx-Clin Study Group (2021) Effect of high-intensity interval training, moderate continuous training, or guideline-based physical activity advice on peak oxygen consumption in patients with heart failure with preserved ejection fraction: a randomized clinical trial. JAMA 325:542. https://doi.org/10.1001/jama.2020.26812

Vacca A, Schiattarella GG (2024) From gut to heart: role of indole-3-propionic acid in HFpEF. Circ Res 134:390–392. https://doi.org/10.1161/CIRCRESAHA.123.323947

doi: 10.1161/CIRCRESAHA.123.323947 pubmed: 38359099

Da Porto A, Cavarape A, Colussi G, Casarsa V, Catena C, Sechi LA (2021) Polyphenols rich diets and risk of type 2 diabetes. Nutrients 13:1445. https://doi.org/10.3390/nu13051445

doi: 10.3390/nu13051445 pubmed: 33923263 pmcid: 8146556

Hussain T, Tan B, Yin Y, Blachier F, Tossou MCB, Rahu N (2016) Oxidative stress and inflammation: what polyphenols can do for us? Oxid Med Cell Longev 2016:1–9. https://doi.org/10.1155/2016/7432797

doi: 10.1155/2016/7432797

Lifestyle interventions in cardiometabolic HFpEF: dietary and exercise modalities.

Journal

Informations de publication

Résumé

Identifiants

Types de publication

Langues

Sous-ensembles de citation

Informations de copyright

Références

Auteurs

Antonio Vacca (A)

Rongling Wang (R)

Natasha Nambiar (N)

Federico Capone (F)

Catherine Farrelly (C)

Ahmed Mostafa (A)

Leonardo A Sechi (LA)

Gabriele G Schiattarella (GG)

Classifications MeSH